We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image:  DOCK10 may serve as a diagnostic marker for insulin-secreting lesions and a potential therapeutic target in insulinoma (photo courtesy of Institute of Science Tokyo)

Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors

Identification of a molecular mechanism underlying abnormal insulin release could refine insulinoma diagnostics. More...
30 Mar 2026
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

A companion diagnostic now enables selection of patients with esophageal or GEJ carcinoma for pembrolizumab based on tumor PD-L1 expression. More...
30 Mar 2026
Image: The guidance recommends easy‑to‑collect tongue swab samples and a cost‑saving sputum pooling strategy for TB and rifampicin‑resistant TB. (photo courtesy of WHO / Enric Catala Contreras)

WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection

The World Health Organization (WHO) has issued new guidelines emphasizing point-of-care testing for tuberculosis. More...
30 Mar 2026
Image: The assay serves as an adjunctive tool in evaluating patients suspected of B-cell lymphoproliferative disorders (photo courtesy of Shutterstock)

First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

Invivoscribe's IdentiClone Dx IGH Assay is the first IVDR-certified assay for IGH clonality detection in patients with suspected B-cell lymphoproliferative disease. More...
30 Mar 2026
DB function failed with error number 0

Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

More...
30 Mar 2026
Image

Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers

Results of the comprehensive study could increase the number of cancer patients recognized as candidates for targeted and immune‑based treatments. More...
30 Mar 2026
Image: The assays run on the cobas i 601 analyzer as part of the cobas Mass Spec solution (photo courtesy of Roche)

New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

Roche’s Ionify® steroid assays are its latest mass spectrometry tests to receive CLIA ‘moderate complexity’ classification. More...
30 Mar 2026
New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Electrolyte Analyzer
BKE-B
INTEGRA BIOSCIENCES AG